Advanced search
Publication Cover
Acta Oncologica Volume 61, 2022 - Issue 12
Journal homepage
847
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor: Survivorship, Rehabilitation and Palliative Care

Active use of electronic patient-reported outcome in kidney cancer and effect on self-reported physical function: PRORECECA study protocol

Ida Marie Lind Rasmussena Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark;b Department of Clinical Medicine, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6226-1201View further author information
ORCID Icon,
Anne Kirstine Hundahl Moellera Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0002-3420-0882View further author information
ORCID Icon,
Anne Vest Soerensena Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0003-3934-7696View further author information
ORCID Icon,
Gitte Perssona Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark;b Department of Clinical Medicine, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-3363-3256View further author information
ORCID Icon,
Gry Assam Taarnhoejc Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0001-7312-7326View further author information
ORCID Icon,
Jesper Andreas Palshofa Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0001-5412-9246View further author information
ORCID Icon &
Helle Pappotb Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;c Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0002-3570-5372View further author information
ORCID Icon show all
Pages 1473-1476 | Received 24 Jun 2022, Accepted 01 Nov 2022, Published online: 09 Dec 2022

References

  • McKay RR, Bosse D, Choueiri TK. Evolving systemic treatment landscape for patients with advanced renal cell carcinoma. J Clin Oncol. 2018;36(36):3615–3623.
  • Powles T, Rini B. Novel agents and drug development needs in advanced clear cell renal cancer. J Clin Oncol. 2018;36(36):3639–3644.
  • Motzer RJ, Penkov K, Haanen J, et al. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380(12):1103–1115.
  • Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med. 2018;378(14):1277–1290.
  • Motzer R, Alekseev B, Rha SY, et al. Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. N Engl J Med. 2021;384(14):1289–1300.
  • Choueiri TK, Powles T, Burotto M, et al. Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2021;384(9):829–841.
  • Rini BI, Plimack ER, Stus V, et al. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380(12):1116–1127.
  • Administration FAD. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims; availability; 2009. Available from: https://www.federalregister.gov/documents/2009/12/09/E9-29273/guidance-for-industry-on-patient-reported-outcome-measures-use-in-medical-product-development-to
  • Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198.
  • Basch E, Deal AM, Kris MG, et al. Symptom monitoring with Patient-Reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565.
  • Atkinson TM, Stover AM, Storfer DF, et al. Patient-reported physical function measures in cancer clinical trials. Epidemiol Rev. 2017;39(1):59–70.
  • Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension. JAMA. 2018;319(5):483–494.
  • Tolstrup LK, Pappot H, Zangger G, et al. Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form. Health Qual Life Outcomes. 2018;16(1):77.
  • Cella D, Grunwald V, Escudier B, et al. Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial. Lancet Oncol. 2019;20(2):297–310.
  • Mouillet G, Fritzsch J, Paget-Bailly S, et al. Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol. Health Qual Life Outcomes. 2019;17(1):25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.